News
The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...
Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from ...
Despite health authorities issuing fresh guidelines to tackle the growing threat of Chikungunya, action on the ground tells a ...
Despite health authorities issuing fresh guidelines to tackle the growing threat of Chikungunya, action on the ground tells a ...
Chandigarh: Amid a steady rise in dengue and chikungunya cases across the state, the Punjab health department directed all ...
The earnings before interest, tax, depreciation and amortization margin rose to 31% from 3%, and Bavarian Nordic maintained guidance for a full-year EBITDA margin of 26%-30% with revenue still seen at ...
According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among children under 18.
Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what ...
Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.
According to the National Center for Vector Borne Disease Control (NCVBDC), Maharashtra recorded 2,726 malaria cases up to ...
As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results